Item request has been placed!
×
Item request cannot be made.
×
Processing Request
A 90 Day, Phase 3,Open Labeled Exploratory Study of RELiZORB
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- المؤلفون: Alcresta Therapeutics, Inc.
- المصدر:
A 90 Day, Phase 3, Open Labeled Exploratory Study of RELiZORB to Evaluate Safety, Tolerability, and Nutrient Absorption in Children With Short Bowel Syndrome Who Are Dependent on Parenteral Nutrition
Freedman S, Orenstein D, Black P, Brown P, McCoy K, Stevens J, Grujic D, Clayton R. Increased Fat Absorption From Enteral Formula Through an In-line Digestive Cartridge in Patients With Cystic Fibrosis. J Pediatr Gastroenterol Nutr. 2017 Jul;65(1):97-101. doi: 10.1097/MPG.0000000000001617.
No Comments.